Phase I renal clearance study of ELND 005 in subjects with renal impairment
Latest Information Update: 28 Mar 2015
At a glance
- Drugs ELND 005 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 28 Mar 2015 New trial record
- 26 Mar 2015 Results published in the Media Release.